CD4 and graft versus host disease: Expression of CD103 marks a subset of peripheral inducible Tregs (about 20–30% of the CD4+FoxP3+ Tregs in the spleen), which inhibit graft-versus-host disease more potently than the CD4+CD25+ Tregs (23, 24).